Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ETS-family transcription factors are a large family of transcription factors unique to animals, characterized by a conserved DNA-binding domain (ETS domain). They regulate gene expression across diverse biological processes including cellular differentiation, cell cycle control, apoptosis, angiogenesis, and immune function. They are implicated in various diseases, particularly cancer, through gene fusions, deregulated expression, and promotion of tumor progression.
Modulation of gene expression through DNA binding and protein-protein interactions; activation or repression of transcription.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ETS-Family Transcription Factors (ETS).